Prolia

Prolia

denosumab

Manufacturer:

Amgen

Distributor:

Zuellig
Concise Prescribing Info
Contents
Denosumab
Indications/Uses
Treatment of osteoporosis in men & postmenopausal women & bone loss in patients undergoing hormone ablation for prostate or breast cancer. Increases bone mineral density & reduces incidence of hip, vertebral & non-vertebral fractures in postmenopausal women.
Dosage/Direction for Use
Contraindications
Special Precautions
Administer Ca & vit D to correct hypocalcemia before initiation. Do not use w/ Xgeva. Skin infections (predominantly cellulitis) may develop. Osteonecrosis of the jaw in patients w/ advanced cancer. Atypical femoral fracture. Severe renal impairment or undergoing dialysis. Pregnancy & lactation. Childn.
Adverse Reactions
Cataracts; pain in extremity. Hypocalcemia.
ATC Classification
M05BX04 - denosumab ; Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.
Presentation/Packing
Form
Prolia soln for inj 60 mg/mL
Packing/Price
1 mL x 1's (P18,490/pre-filled syringe)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in